Strata Critical Medical, Inc. (SRTA) — Capital Reinvestment Ratio

Latest as of March 2026: 1.54x

Strata Critical Medical, Inc. (SRTA) has a Capital Reinvestment Ratio of 1.54x as of March 2026, meaning it reinvests 2% of its operating cash flow ($3.56 Million) in capital expenditures ($5.48 Million). Check Strata Critical Medical, Inc. (SRTA) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.54x
Capex / Operating Cash Flow

Operating Cash Flow

$3.56 Million
USD

Capital Expenditures

$5.48 Million
USD

Data as of

Mar 2026
Most recent filing

Annual Capital Reinvestment Ratio for Strata Critical Medical, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Strata Critical Medical, Inc. from None to None. See SRTA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow